Price To Earnings Ratio 83.85 | Sector PE 70.08 |
PB Ratio 6.55 | Sector PB 9.24 |
EPS 7.93 | Dividend Yield 0.24 |
Today's Volume 1.679 M | 5 Day Avg. Volume 1.704 M |
PEG Ratio 48.75 | Market Cap. ₹ 49,770.00 Cr. |
Time | FORTIS | VS | Industry |
---|---|---|---|
1 Day | 2.61% | 1.38% | |
1 Week | -3.07% | 1.27% | |
1 Month | 9.52% | 6.26% | |
6 Months | 36.48% | 24.26% | |
1 Year | 79.71% | 41.69% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 666.72 | Bearish |
20 | 647.19 | Bullish |
30 | 632.05 | Bullish |
50 | 619.84 | Bullish |
100 | 571.22 | Bullish |
200 | 506.63 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | ||||
---|---|---|---|---|---|---|---|
Operating Activities | 1100.10 | 822.25 | 865.39 | ||||
Investing Activities | -886.37 | -373.70 | -514.38 | ||||
Financing Activities | -86.46 | -471.22 | -517.31 | ||||
Net Cash Flow | 127.27 | -22.67 | -166.29 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
Fortis Healthcare | 2.61 | -3.07 | 9.52 | 36.48 | 79.71 |
Alembic | 3.08 | 7.1 | 7.09 | 1.53 | 1.53 |
Aurobindo Pharma | -0.48 | 1.34 | -10.97 | -5.1 | 14.47 |
Ajanta Pharmaceuticals | -0.58 | 0.06 | 0.06 | 13.87 | 47.58 |
Advanced Enzyme Tech | -1.01 | 2.11 | -17.27 | -0.5 | 13.58 |
Fortis Healthcare Limited is an integrated healthcare provider operating in India. The company's field of activity is mainly health services. It operates in two segments: Healthcare and Diagnostics. Its specialties include cardiology, cosmetology, dentistry, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics and ophthalmology. It operates and manages a network of many specialized hospitals and diagnostic centers. The company's healthcare industries primarily consist of hospitals, diagnostic and specialty day care facilities. It has about 36 health facilities including projects under development, 4000 years of operation and more than 400 diagnostic centers. It operates in India, United Arab Emirates and Sri Lanka. Its subsidiaries include Escorts Heart Institute and Research Center Limited, Fortis Healthstaff Limited and Fortis Asia Healthcare Pte. Ltd, among others.